Cargando…

The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies

BACKGROUND: The International Rare Diseases Research Consortium (IRDiRC) is an international initiative that aims to use research to facilitate rapid diagnosis and treatment of rare diseases. OBJECTIVE: IRDiRC launched the Chrysalis Task Force to identify key financial and nonfinancial factors that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beaverson, Katherine L., Julkowska, Daria, Letinturier, Mary Catherine V., Aartsma-Rus, Annemieke, Austin, Jennifer, Bueren, Juan, Frost, Simon, Hamamura, Misako, Larkindale, Jane, LaRosa, Greg, Magenheim, Rita, Merico, Annamaria, Gerdina Pasmooij, Anna Maria, Pirard, Vinciane, Ekow Thomford, Nicholas, Wada, Michihiko, Wong-Rieger, Durhane, Hartman, Adam L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387802/ https://www.ncbi.nlm.nih.gov/pubmed/37529076 http://dx.doi.org/10.1177/26330040231188979

Ejemplares similares

Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective
por: Austin, Christopher P., et al.
Publicado: (2017)

Progress in Rare Diseases Research 2010–2016: An IRDiRC Perspective
por: Dawkins, Hugh J.S., et al.
Publicado: (2017)

Essential list of medicinal products for rare diseases: recommendations from the IRDiRC Rare Disease Treatment Access Working Group
por: Gahl, William A., et al.
Publicado: (2021)

Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task Force
por: Nabbout, Rima, et al.
Publicado: (2023)

Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patients
por: Zanello, Galliano, et al.
Publicado: (2022)

Measuring what matters to rare disease patients – reflections on the work by the IRDiRC taskforce on patient-centered outcome measures
por: Morel, Thomas, et al.
Publicado: (2017)

‘IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases
por: Lochmüller, Hanns, et al.
Publicado: (2017)

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force
por: Southall, Noel T, et al.
Publicado: (2019)

Chrysalis and Butterfly: Salutatory
Publicado: (1893)

Will CHRYSALIS turn into a butterfly?
por: Fuereder, T.
Publicado: (2022)

Metamorphosis revealed: time-lapse three-dimensional imaging inside a living chrysalis
por: Lowe, Tristan, et al.
Publicado: (2013)

Promoting Undetectable Equals Untransmittable in Sub-Saharan Africa: Implication for Clinical Practice and ART Adherence
por: Thomford, Nicholas Ekow, et al.
Publicado: (2020)

Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study
por: Park, Keunchil, et al.
Publicado: (2021)

Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review
por: Dzobo, Kevin, et al.
Publicado: (2020)

In Vitro Reversible and Time-Dependent CYP450 Inhibition Profiles of Medicinal Herbal Plant Extracts Newbouldia laevis and Cassia abbreviata: Implications for Herb-Drug Interactions
por: Thomford, Nicholas Ekow, et al.
Publicado: (2016)

Psychometric assessment of HIV stigma in patients attending a tertiary facility: An initial validation of the Berger HIV stigma scale in a Ghanaian perspective
por: Thomford, Nicholas Ekow, et al.
Publicado: (2023)

Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
por: Thomford, Nicholas Ekow, et al.
Publicado: (2018)

High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women
por: Kuguyo, Oppah, et al.
Publicado: (2021)

State of the art of rare disease activities around the world: overview of the non-European landscape
por: Wong-Rieger, Durhane
Publicado: (2012)

Advances in Regenerative Medicine and Tissue Engineering: Innovation and Transformation of Medicine
por: Dzobo, Kevin, et al.
Publicado: (2018)

APOL1 genotype associated risk for preeclampsia in African populations: Rationale and protocol design for studies in women of African ancestry in resource limited settings
por: Osafo, Charlotte, et al.
Publicado: (2022)

Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe?
por: Dzobo, Kevin, et al.
Publicado: (2018)

Apolipoprotein E genetic variation, atherogenic index and cardiovascular disease risk assessment in an African population: An analysis of HIV and malaria patients in Ghana
por: Thomford, Nicholas Ekow, et al.
Publicado: (2023)

Zero malaria: a mirage or reality for populations of sub-Saharan Africa in health transition
por: Sarpong, Esther, et al.
Publicado: (2022)

Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
por: Zhou, Guiling, et al.
Publicado: (2023)

Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle
por: Menon, Devidas, et al.
Publicado: (2015)

Review of 11 national policies for rare diseases in the context of key patient needs
por: Dharssi, Safiyya, et al.
Publicado: (2017)

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis
por: Ismail, Rawa Kamaran, et al.
Publicado: (2022)

Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
por: Zhou, Guiling, et al.
Publicado: (2023)

Frames that matter: Increasing the willingness to get the Covid-19 vaccines
por: Diament, Sean M., et al.
Publicado: (2022)

The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices
por: Senthebane, Dimakatso Alice, et al.
Publicado: (2018)

The Use of High-Throughput Phenotyping for Assessment of Heat Stress-Induced Changes in Arabidopsis
por: Gao, Ge, et al.
Publicado: (2020)

The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
por: Senthebane, Dimakatso Alice, et al.
Publicado: (2017)

Reassessing the BODE score as a criterion for listing COPD patients for lung transplantation
por: Pirard, Lionel, et al.
Publicado: (2018)

An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries
por: Ward, Leanne Marie, et al.
Publicado: (2022)

Kinetics and Quality of Microwave-Assisted Drying of Mango (Mangifera indica)
por: Abano, Ernest Ekow
Publicado: (2016)

Unpacking the blackbox of responsible pandemic governance: of COVID-19, multilevel governance and state capacity in Ghana – A Review
por: Arkorful, Vincent Ekow
Publicado: (2022)

Prevalence of COVID-19 genomic variation in Africa: a living systematic review protocol
por: Adjei, George, et al.
Publicado: (2021)

Microscopic identification of possible Clonorchis/Opisthorchis infection in two Ghanaian women with undiagnosed abdominal discomfort: two case reports
por: Asare, Kwame Kumi, et al.
Publicado: (2014)

Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
por: Frebourg, Thierry, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aoaohgcari78pet92bsf2p4g4a